Komori
Muromachi Chemicals (4885) · FactAdvanced

Operating Cash Flow Turning Negative and Decline in Cash Balances

First written in FY2023-Q2. 9 of 13 entries say "Mitigated", first in FY2023. Latest entry: FY2026.

13entries
4years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2023-Q3 – FY2023MitigatedFY2024-Q2 – FY20262023: 420232024: 220242025: 120252026: 62026
Same theme, other companies
Deterioration in Operating Cash Flow Due to Higher Working CapitalA theme 158 companies write about · 158 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2022: 39 of 141 companies on the "Worse" side.

6 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 158 companies compared. The sentences above are computed from all 158.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Cash and cash equivalents at the end of the fiscal year stood at ¥1,917.059 million, an increase of ¥888.990 million from the end of the previous fiscal year. Net cash provided by operating activities was ¥808.089 million, compared with ¥215.961 million in the previous fiscal year.」

    The increase in cash and cash equivalents widened, and operating cash flow also increased from ¥215.961 million in the previous fiscal year to ¥808.089 million.
  2. FY2026-H1MitigatedAnnual report

    「Cash and cash equivalents at the end of the interim accounting period stood at ¥1,846.284 million, an increase of ¥818.215 million from the end of the previous fiscal year. Net cash provided by operating activities was ¥281.507 million, compared with ¥137.174 million in the previous interim accounting period.」

    The increase in cash and cash equivalents widened, and operating cash flow also increased year on year.
  3. FY2025-H1MitigatedAnnual report

    「Cash and cash equivalents at the end of the interim accounting period stood at ¥1,328.809 million, an increase of ¥278.382 million from the end of the previous fiscal year. Net cash provided by operating activities was ¥137.174 million, compared with ¥143.152 million in the previous interim accounting period.」

    Cash and cash equivalents increased by ¥278.382 million from the end of the previous fiscal year, and operating cash flow continued to be positive.
  4. FY2024-Q3MitigatedAnnual report

    「¥101.857 million increase in cash and deposits」

    Cash and deposits increased by ¥101.857 million from the end of the previous fiscal year to ¥954.464 million.
  5. FY2024-Q2MitigatedAnnual report

    「Net cash provided by operating activities was ¥143.152 million, compared with net cash used of ¥58.498 million in the same period of the previous year.」

    Operating cash flow changed from cash used in the same period of the previous year to cash provided of ¥143.152 million, while cash and cash equivalents increased by ¥212.398 million from the end of the previous fiscal year.
  6. FY2024-Q1Continued Decline in Cash and DepositsAnnual report

    「¥137.848 million decrease in cash and deposits」

    Cash and deposits at the end of the quarter decreased by ¥137.848 million from the end of the previous fiscal year to ¥714.758 million.
  7. FY2023MitigatedAnnual report

    「Net cash provided by operating activities was ¥317.189 million, compared with ¥524.905 million in the same period of the previous year.」

    The cash outflow from operating activities reported through the previous quarter was eliminated on a full-year basis, resulting in cash provided of ¥317.189 million. Meanwhile, cash and cash equivalents stood at ¥852.606 million at the end of the fiscal year, down ¥12.754 million from the end of the previous fiscal year.
  8. FY2023-Q3AdvancedAnnual report

    「This was mainly due to increases of ¥218.279 million in merchandise and finished goods and ¥157.652 million in electronically recorded monetary claims, and a ¥184.306 million decrease in cash and deposits.」

    At the end of the third quarter, increases in merchandise and finished goods and electronically recorded monetary claims, together with a ¥184.306 million decrease in cash and deposits, were identified as factors affecting assets.
  9. FY2023-Q2First statedAnnual report

    「Net cash used in operating activities was ¥58.498 million, compared with net cash provided of ¥151.686 million in the same period of the previous year. This mainly reflected cash inflows from pretax quarterly net income of ¥207.911 million and depreciation of ¥55.608 million, and cash outflows from increases of ¥220.842 million in inventories and ¥80.516 million in trade receivables, among other items.」

    Operating cash flow for the cumulative second-quarter period changed from cash provided in the same period of the previous year to cash used of ¥58.498 million, with increases in inventories and trade receivables being the main cash outflow factors. Cash and cash equivalents also decreased by ¥99.909 million from the end of the previous fiscal year.
Moved together

"Results for the nine months ended in the third quarter" moved the same way as this thread, in the same document, in 11 of its 13 moves.

1199876★123456
  1. ★This thread
  2. 1Results for the nine months ended in the third quarter11×
  3. 2Revenue Recognition from Large-Scale Equipment Projects and Solid Sales of Chemical Products9×
  4. 3Decline in sales and operating loss in the health foods business9×
  5. 4Steady sales of core pharmaceuticals and related products8×
  6. 5Operating Losses Widened by Chemicals Business Development Costs and Staff Expansion7×
  7. 6Increase in net assets and equity ratio6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Muromachi Chemicals yet. It last moved in the Earnings presentation of 2026-07-14: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Operating Cash Flow Turning Negative and Decline in Cash Balances | MUROMACHI CHEMICALS INC. (4885) | Komori